|
|
Other links at Articles > Pharmacists |
| 1. |
RANKL Levels May Predict Response to TNF Blockers in Rheumatoid Arthritis
|
|
|
In patients with rheumatoid arthritis, baseline serum RANKL (receptor activator for nuclear factor kappa-B ligand) levels and the RANKL-to-osteoprotegerin (OPG) ratio may help predict a therapeutic response to TNF-antagonist therapy, according to results of a study conducted in Spain. Reuters Health Information
|
| 4. |
Hypertension Potentiates the Risk of Doxorubicin Cardiotoxicity
|
|
|
Doxorubicin is often withheld from older patients because advanced age -- along with heart disease, diabetes, and hypertension -- are known to increase the risk of doxorubicin-related cardiotoxicity. Now, in a study of older adults with diffuse large B-cell lymphoma (DLBCL), researchers have found that of all these factors, only hypertension synergistically potentiates the risk of cardiac effects. Reuters Health Information
|
|
|